文献速递主动脉疾病颈动脉与弓上血管

混合腔内方法治疗异常锁骨下动脉瘤的10年经验

A 10-Year Experience Using a Hybrid Endovascular Approach to Treat Aberrant Subclavian Arterial Aneurysms.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

单中心前瞻性注册研究纳入10例异常锁骨下动脉瘤患者,采用解剖外开放弓部分支血运重建联合主动脉弓腔内隔绝术。所有患者均需双侧锁骨下动脉血运重建/隔绝以实现>20 mm近端锚定区。无重大并发症,吞咽困难均缓解,随访平均41个月显示持久疗效。

要点

  • 混合腔内方法治疗异常锁骨下动脉瘤手术并发症低。
  • 双侧锁骨下动脉需血运重建以创造>20 mm近端锚定区。
  • 分期手术可减少双侧颈部暴露导致的气道水肿。

核心结论

  • 混合修复技术治疗异常锁骨下动脉瘤手术并发症低,随访显示持久且能缓解食管压迫症状。

研究设计与样本

  • 单中心前瞻性注册研究,纳入10例接受混合腔内治疗的异常锁骨下动脉瘤患者。

主要发现

  • 10例患者中女性8例、男性2例,年龄32至85岁。
  • presenting symptoms为吞咽困难9例和急性B型主动脉夹层1例。
  • 无重大并发症包括脊髓缺血、卒中、颅神经缺损、手臂缺血、入路部位并发症或伤口并发症。
  • 住院时间6至21天,随访平均41个月所有患者吞咽困难缓解。
  • 7例定向影像显示无内漏、动脉瘤尺寸退缩或稳定、所有锁骨下血运重建通畅。

关键数值与推荐

  • 所有患者需双侧锁骨下动脉血运重建/隔绝以实现>20 mm近端主动脉锚定区(位于颈总动脉起源远端)。
  • TEVAR使用单件装置(100-157 mm),除主动脉夹层需覆盖降胸主动脉全长。
  • 锁骨下血运重建采用颈动脉-锁骨下旁路(聚四氟乙烯,17例)或锁骨下转位(3例),近端闭塞采用Amplatzer II封堵器栓塞(11例)或结扎(9例)。

临床怎么用

  • 对于异常锁骨下动脉瘤导致食管压迫的患者,可考虑混合腔内方法,但需双侧锁骨下血运重建以创造近端锚定区。
  • 多数情况下分期(1-2天)进行解剖外血运重建和胸主动脉腔内修复,以减少双侧颈部暴露导致的气道水肿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the study was to describe a single-center experience using combined extra-anatomic open arch branch revascularization with aortic arch endovascular exclusion for treatment of aberrant subclavian artery aneurysms. METHODS: All patients undergoing management of aberrant subclavian aneurysms were identified from a prospective patient registry. Means of revascularization included carotid-subclavian bypass or subclavian transposition, and origin occlusion was performed by surgical ligation or endovascular embolization at surgeon discretion. Completion of aneurysm exclusion was performed using available distal arch/thoracic aortic endografts (TEVARs) using standard oversizing. Procedures were staged as appropriate based on patient condition. RESULTS: Ten patients, 8 females and 2 males ranging from 32 to 85 years of age, were identified. Presenting symptoms were dysphagia (n = 9) and acute type B aortic dissection (n = 1). All patients required revascularization/exclusion of bilateral subclavian arteries to enable >20 mm proximal aortic fixation distal to the common carotid origins for the arch endograft. TEVAR with planned coverage of both subclavian origins extending into the proximal descending thoracic aorta was performed using transfemoral access (n = 9) or iliac conduit (n = 1) and required a single device (100-157 mm) in all cases except the aortic dissection which required total length coverage of the descending thoracic aorta. Extra-anatomic revascularization and thoracic endografting were staged by 1-2 days in most cases to minimize potential airway edema from bilateral neck exposures. Subclavian revascularization was performed by carotid-subclavian bypass using polytetrafluoroethylene (n = 17) or subclavian transposition (n = 3) with proximal occlusion using embolization with an Amplatzer II plug (n = 11) or ligation (n = 9). No major complications occurred including spinal cord ischemia, stroke, cranial nerve deficit, arm ischemia, access site complications, or wound complications. Length of stay ranged from 6 to 21 days with all patients having resolution of dysphagia on follow-up (mean 41 months). Directed imaging was available for 7 patients demonstrating the absence of endoleak, regression or stability of aneurysm size, and patency of all subclavian revascularizations. CONCLUSIONS: We present a hybrid repair technique with low operative morbidity that has shown to be durable in follow-up and to provide symptomatic relief for patients with aberrant subclavian artery aneurysms causing esophageal compression.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wooster M, Back M, Sutzko D, et al. A 10-Year Experience Using a Hybrid Endovascular Approach to Treat Aberrant Subclavian Arterial Aneurysms. Ann Vasc Surg. 2017. PMID: 28479468. doi:10.1016/j.avsg.2017.03.174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。